A detailed history of St Germain D J CO Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, St Germain D J CO Inc holds 67,560 shares of ABBV stock, worth $12.2 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
67,560
Previous 67,444 0.17%
Holding current value
$12.2 Million
Previous $11.6 Million 15.34%
% of portfolio
0.63%
Previous 0.57%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$163.84 - $199.33 $19,005 - $23,122
116 Added 0.17%
67,560 $13.3 Million
Q2 2024

Jul 08, 2024

SELL
$154.79 - $180.76 $18,265 - $21,329
-118 Reduced 0.17%
67,444 $11.6 Million
Q1 2024

Apr 02, 2024

BUY
$159.82 - $182.1 $54,338 - $61,914
340 Added 0.51%
67,562 $12.3 Million
Q4 2023

Jan 02, 2024

BUY
$137.6 - $154.97 $253,321 - $285,299
1,841 Added 2.82%
67,222 $10.4 Million
Q3 2023

Oct 23, 2023

SELL
$133.59 - $154.65 $752,378 - $870,988
-5,632 Reduced 7.93%
65,381 $9.75 Million
Q2 2023

Sep 07, 2023

SELL
$132.51 - $164.9 $7.91 Million - $9.84 Million
-59,695 Reduced 45.67%
71,013 $9.57 Million
Q4 2022

Feb 27, 2023

BUY
$138.31 - $165.87 $8.17 Million - $9.8 Million
59,077 Added 82.47%
130,708 $21.1 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $40,735 - $51,788
296 Added 0.41%
71,631 $11 Million
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $1.26 Million - $1.56 Million
-9,529 Reduced 11.78%
71,335 $11.6 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $493,103 - $623,918
4,590 Added 6.02%
80,864 $10.9 Million
Q3 2021

Nov 03, 2021

SELL
$106.4 - $120.78 $173,538 - $196,992
-1,631 Reduced 2.09%
76,274 $8.23 Million
Q2 2021

Jul 28, 2021

BUY
$105.21 - $117.21 $13,151 - $14,651
125 Added 0.16%
77,905 $8.78 Million
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $656,766 - $723,020
6,420 Added 9.0%
77,780 $8.42 Million
Q4 2020

Feb 04, 2021

BUY
$80.49 - $108.67 $63,667 - $85,957
791 Added 1.12%
71,360 $7.65 Million
Q3 2020

Nov 10, 2020

SELL
$85.91 - $100.83 $67,525 - $79,252
-786 Reduced 1.1%
70,569 $6.18 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $146 - $196
2 Added 0.0%
71,355 $7.01 Million
Q1 2020

May 13, 2020

SELL
$64.5 - $97.79 $106,941 - $162,135
-1,658 Reduced 2.27%
71,353 $5.44 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $4.37 Million - $5.47 Million
60,654 Added 490.85%
73,011 $6.46 Million
Q3 2019

Oct 17, 2019

SELL
$62.98 - $75.72 $22,043 - $26,502
-350 Reduced 2.75%
12,357 $936,000
Q2 2019

Jul 24, 2019

SELL
$65.7 - $83.98 $79,168 - $101,195
-1,205 Reduced 8.66%
12,707 $924,000
Q1 2019

May 02, 2019

SELL
$77.14 - $90.79 $5,014 - $5,901
-65 Reduced 0.47%
13,912 $1.12 Million
Q4 2018

Feb 05, 2019

BUY
$77.85 - $96.01 $96,923 - $119,532
1,245 Added 9.78%
13,977 $1.29 Million
Q3 2018

Oct 23, 2018

BUY
$88.91 - $98.84 $48,722 - $54,164
548 Added 4.5%
12,732 $1.2 Million
Q2 2018

Aug 07, 2018

BUY
$89.78 - $106.23 $153,703 - $181,865
1,712 Added 16.35%
12,184 $1.13 Million
Q1 2018

Apr 20, 2018

BUY
$92.01 - $123.21 $448,732 - $600,895
4,877 Added 87.17%
10,472 $991,000
Q4 2017

Feb 13, 2018

BUY
$89.56 - $98.21 $189,688 - $208,008
2,118 Added 60.91%
5,595 $541,000
Q3 2017

Oct 31, 2017

BUY
$69.85 - $89.22 $242,868 - $310,217
3,477
3,477 $309,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track St Germain D J CO Inc Portfolio

Follow St Germain D J CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of St Germain D J CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on St Germain D J CO Inc with notifications on news.